Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02934555 · ClinicalTrials.gov registry record · Phase 2
Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest
A Phase 2 study of Cardiac Arrest, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT02934555: Completed Phase 2 study of Cardiac Arrest, sponsored by Beth Israel Deaconess Medical Center.
NCT02934555 is a Phase 2 study of Cardiac Arrest that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 48 participants, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02934555, a Phase 2 study of Cardiac Arrest, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.
Primary Outcome
Total (oxidized and reduced form) coenzyme Q10
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ensure
- DRUG Ubiquinol
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-06-02 |
| Phase | Phase 2 |
What the finished NCT02934555 record still lists
NCT02934555 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 2 interventions - of which Ensure is the first listed.
NCT02934555 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02934555 about?
NCT02934555 is a clinical study titled "Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest". To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.
What is the current status of trial NCT02934555?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2016-03. Estimated completion is 2019-06-02.
What conditions does trial NCT02934555 study?
This clinical trial studies the following conditions: Cardiac Arrest.
What interventions are being tested in trial NCT02934555?
The interventions under investigation include: Ensure (DIETARY_SUPPLEMENT), Ubiquinol (DRUG).
Who is sponsoring clinical trial NCT02934555?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02934555 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02934555's enrollment target sits among peer trials
48 23rd of 31 higher than 9 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surviving PEA in Roanoke (SPEAR) Study
RECRUITING · Phase 2
-
Early Amiodarone in Shockable Cardiac Arrest
RECRUITING · Phase 3
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Resuscitative TEE Collaborative Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia